Annual CFF
$24.39 M
+$25.66 M+2029.67%
December 1, 2023
Summary
- As of February 8, 2025, ARTV annual cash flow from financing activities is $24.39 million, with the most recent change of +$25.66 million (+2029.67%) on December 1, 2023.
- During the last 3 years, ARTV annual CFF has fallen by -$13.00 million (-34.77%).
- ARTV annual CFF is now -84.03% below its all-time high of $152.75 million, reached on December 1, 2021.
Performance
ARTV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$163.87 M
+$165.49 M+10240.59%
September 1, 2024
Summary
- As of February 8, 2025, ARTV quarterly cash flow from financing activities is $163.87 million, with the most recent change of +$165.49 million (+10240.59%) on September 1, 2024.
- Over the past year, ARTV quarterly CFF has increased by +$140.44 million (+599.38%).
- ARTV quarterly CFF is now at all-time high.
Performance
ARTV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$163.22 M
+$140.44 M+616.59%
September 1, 2024
Summary
- As of February 8, 2025, ARTV TTM cash flow from financing activities is $163.22 million, with the most recent change of +$140.44 million (+616.59%) on September 1, 2024.
- Over the past year, ARTV TTM CFF has increased by +$139.79 million (+596.65%).
- ARTV TTM CFF is now at all-time high.
Performance
ARTV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ARTV Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2029.7% | +599.4% | +596.6% |
| 3 y3 years | -34.8% | +10000.0% | +10000.0% |
| 5 y5 years | - | +10000.0% | +10000.0% |
ARTV Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.0% | +2029.7% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | -84.0% | +2029.7% | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | -84.0% | +2029.7% | at high | >+9999.0% | at high | >+9999.0% |
Artiva Biotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $163.87 M(<-9900.0%) | $163.22 M(+616.6%) |
| Jun 2024 | - | -$1.62 M(<-9900.0%) | $22.78 M(-6.7%) |
| Mar 2024 | - | $0.00(-100.0%) | $24.40 M(+0.0%) |
| Dec 2023 | $24.39 M | $962.00 K(-95.9%) | $24.39 M(+4.1%) |
| Sep 2023 | - | $23.43 M(>+9900.0%) | $23.43 M(<-9900.0%) |
| Jun 2023 | - | $10.00 K(-183.3%) | -$2000.00(-83.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.00 K(-96.1%) | -$12.00 K(-96.1%) |
| Dec 2022 | -$1.26 M(-100.8%) | - | - |
| Mar 2022 | - | -$305.00 K(-100.2%) | -$305.00 K(-100.2%) |
| Dec 2021 | $152.75 M(+308.5%) | - | - |
| Mar 2021 | - | $153.98 M | $153.98 M |
| Dec 2020 | $37.40 M | - | - |
FAQ
- What is Artiva Biotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics annual CFF year-on-year change?
- What is Artiva Biotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics quarterly CFF year-on-year change?
- What is Artiva Biotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics TTM CFF year-on-year change?
What is Artiva Biotherapeutics annual cash flow from financing activities?
The current annual CFF of ARTV is $24.39 M
What is the all time high annual CFF for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high annual cash flow from financing activities is $152.75 M
What is Artiva Biotherapeutics annual CFF year-on-year change?
Over the past year, ARTV annual cash flow from financing activities has changed by +$25.66 M (+2029.67%)
What is Artiva Biotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ARTV is $163.87 M
What is the all time high quarterly CFF for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high quarterly cash flow from financing activities is $163.87 M
What is Artiva Biotherapeutics quarterly CFF year-on-year change?
Over the past year, ARTV quarterly cash flow from financing activities has changed by +$140.44 M (+599.38%)
What is Artiva Biotherapeutics TTM cash flow from financing activities?
The current TTM CFF of ARTV is $163.22 M
What is the all time high TTM CFF for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high TTM cash flow from financing activities is $163.22 M
What is Artiva Biotherapeutics TTM CFF year-on-year change?
Over the past year, ARTV TTM cash flow from financing activities has changed by +$139.79 M (+596.65%)